SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFC14A - Definitive proxy statement, contested solicitations:
SEC Accession No. 0001047469-10-004189
Filing Date
2010-04-26
Accepted
2010-04-26 17:04:40
Documents
3
Effectiveness Date
2010-04-26

Document Format Files

Seq Description Document Type Size
1 DEFC14A a2198211zdefc14a.htm DEFC14A 2250695
2 G1032331.JPG g1032331.jpg GRAPHIC 18303
3 G949067.JPG g949067.jpg GRAPHIC 8316
  Complete submission text file 0001047469-10-004189.txt   2289602
Mailing Address 500 KENDALL STREET CAMBRIDGE MA 02142
Business Address 500 KENDALL STREET CAMBRIDGE MA 02142 6172527500
GENZYME CORP (Filed by) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEFC14A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 500 KENDALL STREET CAMBRIDGE MA 02142
Business Address 500 KENDALL STREET CAMBRIDGE MA 02142 6172527500
GENZYME CORP (Subject) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEFC14A | Act: 34 | File No.: 000-14680 | Film No.: 10770919
SIC: 2836 Biological Products, (No Diagnostic Substances)